Andrea Necchi: A Clinical Gene Therapy Study with Hematopoietic Stem Cells for the Treatment of RCC

Andrea Necchi, Head of Genitourinary Medical Oncology at Ospedale San RaffaeleOspedale, shared a post on LinkedIn:

“A Clinical Gene Therapy Study with Hematopoietic Stem Cells for the Treatment, with Single Dose of Temferon, of Patients with Metastatic Renal Cell Carcinoma (Nasdaq: GNTA) San Raffaele Telethon Institute for Gene Therapy (SR-Tiget).”